Mortality rate of osteosarcoma patients

If you are diagnosed with osteosarcoma, it is undoubtedly a bolt from the blue. Even if you have a good psychological quality, you cannot accept this fact. Who can face malignant tumors calmly? We actively treat and face birth, aging, illness and death calmly. Now let's talk about the mortality rate of osteosarcoma patients:

From the patient's perspective, osteosarcoma can be considered a cancer on the bone. But from a professional perspective, lesions originating from epithelial cell tissue are called "cancers", such as gastric cancer, liver cancer, skin cancer, etc.; lesions originating from mesenchymal tissue are called "sarcomas", including osteosarcoma, chondrosarcoma, synovial sarcoma, etc. In other words, there is a certain difference between "cancer" and "sarcoma", but it is acceptable for ordinary people to call osteosarcoma bone cancer.

Are the incidence and mortality rates of osteosarcoma high? According to foreign literature reports, the incidence of osteosarcoma among blacks, Hispanics and whites is about 5 to 6 people per 1 million people each year. Among malignant tumors in children, the incidence of osteosarcoma ranks eighth. Osteosarcoma is the most common primary malignant tumor in the bone department, accounting for 44% of all primary malignant tumors in the bone department. Therefore, the incidence of osteosarcoma is relatively high.

Osteosarcoma is a highly malignant tumor. Before the 1970s, the mortality rate of the disease was over 90%, and the five-year survival rate was less than 10%. Now, after continuous efforts and research by bone tumor specialists, with active and correct treatment, the five-year survival rate of patients is about 70%. Our department has reached the top level in the country in the treatment of osteosarcoma, and is also at the leading level in the world.

Osteosarcoma should be treated surgically whenever possible. Surgery must be radically removed to avoid local recurrence. At present, limb salvage has become the main surgical procedure for osteosarcoma, but when limb salvage is not suitable or unconditional, amputation should be performed decisively. Chemotherapy is not necessary before surgery, but standardized chemotherapy must be performed after surgery. The characteristic of osteosarcoma is that tumor cells directly form bone-like tissue, so it is also called osteosarcoma, but osteosarcoma cannot be ruled out even if the tumor's bone formation process is not obvious. The survival period of bone cancer patients generally has three years of survival, five years of survival, and ten years of survival, which refers to survival of three years, five years, and more than ten years after surgery, respectively. The medical community has its corresponding cure standards for different degrees of cancer. Regarding the issue of patient survival, it also depends on the individual. Some people with better postoperative results can live like normal people, and can live to 70, 80 years old or even older like normal people. For the treatment of cancer, the key lies in early detection and the patient's positive attitude.

However, due to the emergence of neoadjuvant chemotherapy, especially with adequate doses and reasonable regimens, the survival rate has been significantly improved. The efficacy of osteosarcoma is evaluated by the statistical 5-year survival rate. Under the most scientific and reasonable treatment, the 5-year survival rate of osteosarcoma can reach more than 70%, and patients who live for more than 5 years have a more than 90% chance of long-term survival. From our experience, osteosarcoma is most likely to recur and metastasize within 2 years after treatment. If there is no recurrence and metastasis within 2 years, it is basically possible to control it. The recurrence rate five years after surgery is relatively high. Regular follow-up and regular medication are required after surgery. The difficulty of tumor treatment lies in the easy recurrence and metastasis. Patients can take anti-cancer Chinese patent medicine oral liquid, which is safe, inhibits and eliminates tumors while improving immunity, regulating internal balance, and fundamentally preventing recurrence and metastasis.

Some osteosarcoma patients fail to detect the disease after recurrence and miss the best time for treatment, which leads to worsening of the disease. At this time, life may be in danger at any time. The treatment of osteosarcoma recurrence is the same as the treatment of osteosarcoma. It is important to take systematic treatment in the early stage. At the same time, attention should be paid to the psychological care of patients with osteosarcoma recurrence. However, early detection and timely treatment have greatly improved the survival rate of the disease.

With treatment and various immune factors from the body, life will continue tenaciously. However, if it is not treated, osteosarcoma cells will metastasize to the lungs and life will be directly affected.